In a former Boeing manufacturing facility near Seattle’s waterfront, a six-year old startup is readying a system it says will change surgery.
Proprio‘s technology enables surgeons to see key structures on a screen in three dimensions in real time. The system helps clinicians place incisions and guide placement of hardware, such as devices that can help straighten a spine.
The name “Proprio” is a play on the word “proprioception,” the body’s ability to sense its own position in space, said CEO and co-founder Gabriel Jones during a recent tour of the company’s headquarters.
“For surgeons, that’s incredibly important,” he said. “They need to understand how the anatomy and the biology react, how they can treat it.”
The company, said Jones, is “about enhancing what clinicians can do.”
Proprio has submitted its marketing application to the U.S. Food and Drug Administration and is expecting clearance for the system, called Paradigm, in early 2023. Multiple clinical sites at medical institutions are poised to start using the product if the FDA gives it the green light, and commercial launch is expected to follow, said Jones.
The system has been tested primarily for spine and cranial surgery, some of the biggest sources of revenue for hospital systems and a target market for Proprio.
Image Credit: Proprio